Pancreatic Cancer Research

ResearcherJilin UniversityActive in the last 2 years

Haixin Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0245-2102; OpenAlex author ID A5036534166. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 4 papers · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 10

  1. RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2026.218560↗
  2. HDAC5 depletion promotes hyper-acetylation of FOXA1 and potentiates HIF1α transcriptional activation in pancreatic cancer. First author DOI 10.1016/j.molcel.2026.06.022↗
  3. BAP1 Represses Sequential Activation of IRAKs and NF-κB Signaling in Pancreatic Cancer. Co-author DOI 10.7150/ijbs.104977↗
  4. HMGA2 overexpression activates IGF2BP2 to stabilize APLP2 via m6A modification and promote pancreatic cancer progression. Co-author DOI 10.1016/j.heliyon.2024.e27268↗
  5. RRM2 promotes liver metastasis of pancreatic cancer by stabilizing YBX1 and activating the TGF-beta pathway. Co-author DOI 10.1016/j.isci.2024.110864↗
  6. HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-21-4362↗
  7. Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis. Co-author DOI 10.1186/s12885-022-09463-x↗
  8. CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression. First author DOI 10.7150/ijbs.68995↗
  9. HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer. Co-author DOI 10.7150/thno.69444↗
  10. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review. Last author DOI 10.2147/ott.s207963↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gengdu Qin · 5 shared papers, 2022–2026 · strength 1.02
  2. Yingke Zhou · 5 shared papers, 2022–2026 · strength 0.89
  3. Heshui Wu · 5 shared papers, 2022–2026 · strength 0.89
  4. Penglin Pan · 3 shared papers, 2022–2026 · strength 0.55
  5. Zhouyuan Du · 2 shared papers, 2024 · strength 0.52
  6. Shanmiao Gou · 2 shared papers, 2025–2026 · strength 0.47
  7. Taoyu Chen · 2 shared papers, 2022–2026 · strength 0.37
  8. Jinru Xue · 2 shared papers, 2019–2022 · strength 0.29
  9. Erna Jia · 2 shared papers, 2019–2022 · strength 0.29
  10. Yan Sun · 2 shared papers, 2022 · strength 0.29
  11. Xin Jin · 2 shared papers, 2022 · strength 0.29
  12. Ke Liu · 1 shared paper, 2024 · strength 0.28
  13. Yi Zhou · 1 shared paper, 2026 · strength 0.28
  14. Dianyun Ren · 2 shared papers, 2022 · strength 0.27
  15. Wei Li · 1 shared paper, 2024 · strength 0.24
  16. Tao Liu · 1 shared paper, 2024 · strength 0.24
  17. Yuhan Zhao · 1 shared paper, 2025 · strength 0.24
  18. Huan Zhang · 1 shared paper, 2022 · strength 0.15
  19. Hongkun Cai · 1 shared paper, 2022 · strength 0.15
  20. Feng Guo · 1 shared paper, 2022 · strength 0.15
  21. Shikai Zhu · 1 shared paper, 2022 · strength 0.14
  22. Jingyuan Zhao · 1 shared paper, 2022 · strength 0.14
  23. Jian Shen · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.